Poor countries fall into the vaccine crisis as a result of Punewala’s mistake
At a time when the world was struggling to cope with the Corona crisis last year, the son of India’s billionaire Cyrus Punewala was planning a business using the epidemic. He is Adar Punewala, Chief Executive Officer (CEO) of Seram Institute.
The Seram Institute of India is the largest vaccine manufacturer in the world. Punewala promised to use his organization to supply corona vaccine to different countries of the world. Raised billions of US dollars. But in the end he could not keep his promise. Bangladesh has also suffered from this.
According to US media CNN, the coroner’s vaccine production plan was a big decision for Punewala. Because, no vaccine came in the market at that time. All were in the testing phase. The Oxford-AstraZeneca vaccine was the most promising. With that, Punewala decided to move forward.
Punewala told CNN, “We were going to take stock of the risks we were taking. But to be honest, I didn’t see any other way at that time. I just thought, if I don’t go one way or the other, I will be in trouble later. ‘
55 crore outside with an investment of 60 crore
Different countries of the world paid for them by relying on the best. Everything was going according to plan. The estrogen vaccine was approved in the United Kingdom in December 2020. In India at that time the name of Punewala was in the mouths of people.
Chemicals, glass vials and raw materials were purchased at a cost of 600 million to produce the AstraZeneca vaccine, Punewala said. Of this, কোটি 250 million came from Serum’s own capital. The Bill and Melinda Gates Foundation received 300 million. The agreement with the agency was that Serum would provide low-cost vaccines to low-income countries. The rest of the money is raised in advance from different countries of the world. It was said that the vaccine will be given step by step when the production starts.
Under an agreement with the Gates Foundation and Gavi, a global vaccine alliance, the Serum Institute agreed to provide 200 million vaccines to at least 92 countries. Punewala said all this happened before the AstraZeneca vaccine was approved. If the results of the vaccine were negative at the end of the laboratory trial, Serum would have to produce the vaccine and throw it away.
But in the end the ticker came on the market. And by May 2020, under an agreement with Gavi, Serum had supplied 30 million doses of vaccine to various countries around the world, including India.
Punewala’s work was hampered by a second wave of corona in India. At that time, more than four lakh people were being infected in the country every day. Experts say the actual number of infections is much higher. Only 2% of India’s 1.3 billion people were vaccinated. Ticker stocks were also low in the country at that time. There were fears that India would soon fall into a crisis.
Due to this, the government banned the export of corona vaccine from India. As a result, the supply of vaccines abroad has stopped. “I have always been a patriot,” Punewala told CNN. If the country needs us, we have to do as they say. We had no other choice. ‘
Poor countries in the vaccine crisis
The world’s poorest countries are in crisis if they stop providing the best vaccines. The director of the African Disease Control Authority said India’s ban on vaccine exports could be a “disaster” for the continent. In many countries, from neighboring Nepal to Kenya, the first dose of the vaccine was given. However, after receiving the vaccine, there was uncertainty about the second dose.
CNN has raised the question as to why Gavi relied so much on Serum for the corona vaccine. In response, a spokesman for Gavy said there were only a handful of vaccines on the market at the beginning of 2021. And it was normal to make deals with them keeping in mind the capabilities of the best.
However, Geoffrey Lazarus, an expert at the Barcelona Institute of Global Health, said Gavi’s decision was wrong. According to him, relying on just one producer was not the right decision at all.
Bangladesh also fell into uncertainty
Bangladesh also made an agreement with Seram to get the vaccine. In January this year, the Department of Drug Administration of Bangladesh approved the emergency use of Seram vaccine. Then the first shipment of Ticker came on 25th January. The first consignment received 50 lakh vaccines. It was said that after that 50 million per month and 3 crore vaccines will come in six months. Later in February, Seram sent 20 lakh vaccines. No vaccines were sent in March and April.